Oñate, G, Garrido, A, Arnan, M, Pomares, H, Alonso, E, Tormo, M, Diaz-Beya, M, Vives, S, Zamora, L, Sampol, A, Coll, R, Salamero, O, Cervera, M, Garcia, A, Vall-Llovera, F, Garcia-Avila, S, Bargay, J, Ortin, X, Iranzo, E, Guijarro, F, Pratcorona, M, Nomdedeu, JF, Esteve, J, Sierra, J. Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group. Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-024-01205-5. PMID:39799145. IF:11.600(Q1/1D).

de Winter, DP, Verweij, EJT, Debeer, A, Devlieger, R, Lewi, L, Verbeeck, S, Maurice, P, Jouannic, JM, Guillemin, MG, Mailloux, A, dos Santos, MCP, Pacheco, CADS, Moreira, MEL, Vaena, MMD, Bohlin, K, Tiblad, E, Thorup, E, Petersen, OB, Sanchez-Holgado, M, Llorente, AV, Poljak, B, Khalil, A, Le Duc, K, Ghesquiere, L, Krivec, JL, Soltirovska-Salamon, A, Dame, C, Blank, JD, Hohnecker, A, Saxonhouse, M, Connors, NK, Geipel, A, Rath, J, Prasad, S, van Wyk, L, Geerts, L, Schuler, R, Thon, N, Leibovitch, L, Cohen, S, Canul-Euan, AA, Kelly, E, Raghuram, K, Cavigioli, F, Colombo, SFG, Elanjikal, Z, Brayley, J, Pfurtscheller, D, Pichler, G, Grisi, AGA, Navarro, EJJC, Pereira-Nunes, J, Soares, H, Zhou, M, Borau, MJG, Calderon, EM, Galletti, MF, Mariani, GL, Mackin, D, Malone, F, Lampland, A, Tse, WT, Castleman, J, van der Bom, JG, de Haas, M, Lopriore, E, Fetus Newborn DIONYSUS Investigators. Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn. JAMA Network Open. 2025; 8(1)DOI:10.1001/jamanetworkopen.2024.54330. PMID:39792381. IF:9.700(Q1/1D).

Mcglinchey, E, Fortea, J, Vava, B, Andrews, Y, Ranchod, K, Kleinhans, A. Raising awareness and addressing inequities for people with Down syndrome in South Africa. International Journal for Equity in Health. 2025; 24(1)DOI:10.1186/s12939-024-02349-3. PMID:39789562. IF:4.100(Q1/2D).

Brand, E, Linhart, A, Deegan, P, Jurcut, R, Pisani, A, Torra, R, Feldt-Rasmussen, U. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03500-7. PMID:39773286. IF:3.500(Q2/4D).

Schoser, B, Attarian, S, Graham, R, Holdbrook, F, Goldman, M, Díaz-Manera, J. Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease. JOURNAL OF NEUROLOGY. 2025; 272(1)DOI:10.1007/s00415-024-12843-x. PMID:39775064. IF:4.600(Q1/2D).

Salas, MQ, Solano, MT, González, MB, Gómez, MA, Fox, L, Artigas, MDP, Santamaría, A, González, MDQ, Salinas, AS, Camacho, JMS, Alvaro, VI, Abdallahi-Lefdil, Z, Navascues, JC, Pardo, L, Fernández-Luis, S, Suárez, LPV, Villar, S, Beorlegui-Murillo, P, Esquirol, A, García, II, González, SR, Mussetti, A, Lavilla, E, Lopez-Marín, J, Filaferro, S, Cedillo, A, Bento, L, Sureda, A. Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care. Frontiers in Immunology. 2025; 15DOI:10.3389/fimmu.2024.1512154. PMID:39840039. IF:5.900(Q1/2D).

Mayoral, V, Galvez, R, Ferrándiz, M, Vázquez, XM, Cordero-García, C, Montero, AA, Pérez, C, Pérez-Páramo, M. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety. Frontiers In Pain Research. 2025; 5DOI:10.3389/fpain.2024.1513597. PMID:39839199. IF:(Q/D).

Bougacha, S, Roquet, D, Landeau, B, Saul, E, Naveau, M, Sherif, S, Bejanin, A, Dhenain, M, Raj, A, Vivien, D, Chetelat, G, Alzheimers Dis Neuroimaging Initiative. Contributions of connectional pathways to shaping Alzheimer's disease pathologies. Brain Communications. 2025; 7(1)DOI:10.1093/braincomms/fcae459. PMID:. IF:(Q/D).

Flores-Aguilar, L, Hamlett, ED, Araya, P, Barone, E, Bhattacharyya, A, Carmona-Iragui, M, Chan, L, Christian, B, Costa, ACS, Costanzo, F, Soriano, LD, Dierssen, M, Eichler, EE, Fisher, E, Galbraith, M, Ghosh, S, Gimenez, S, Guedj, F, Guidi, S, Iulita, MF, Mobley, W, Pelleri, MC, Potier, MC, Rabin, KR, Rachubinski, A, Rebillat, AS, Rubenstein, E, Saternos, H, Sordo, L, Strydom, A, Valle-Tamayo, N, Waugh, KA, Yu, E, Zeldich, E, Busciglio, J, Head, E. Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society. NEUROMOLECULAR MEDICINE. 2025; 27(1)DOI:10.1007/s12017-024-08824-y. PMID:39756004. IF:3.900(Q2/3D).

Querol, L, Dalakas, MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(1)DOI:10.1212/NXI.0000000000200365. PMID:39671536. IF:7.500(Q1/1D).

Reyes-Leiva, D, Carbayo, A, Vesperinas-Castro, A, Rojas-Garcia, R, Querol, L, Turon-Sans, J, Pla-Junca, F, Olivé, M, Gallardo, E, Pujades-Rodriguez, M, Cortés-Vicente, E. Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16463. PMID:39624955. IF:3.900(Q1/3D).

Cortes-Vicente, E, Guerrero-Sola, A, Caballero-Martinez, F, Campos-Lucas, FJ, Gómez-Salgado, J, Monge-Martin, D, Alvarez-Velasco, R. Practitioner's perception of myasthenia gravis management recommendations in clinical practice: a cross-sectional survey study. Therapeutic Advances in Chronic Disease. 2025; 16DOI:10.1177/20406223251368063. PMID:40949050. IF:2.800(Q2/5D).

Rodríguez-Antigüedad, J, Olmedo-Saura, G, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review. Therapeutic Advances in Neurological Disorders. 2025; 18DOI:10.1177/17562864251336903. PMID:40433403. IF:4.100(Q1/2D).

Portella, MJ, Arteaga-Henríquez, G, de Diego-Adeliño, J, Trujols, J, Puigdemont, D, Pérez, J, Alemany, C, Carrasco-Hernández, J, Udina, M, Cardoner, N, Vicent-Gil, M. Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?. GENERAL HOSPITAL PSYCHIATRY. 2025; 92DOI:10.1016/j.genhosppsych.2024.10.003. PMID:39395857. IF:3.700(Q1/3D).

Seppälä, J, Grasa, E, Alonso-Solis, A, Roldan-Bejarano, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazán, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Reixach, E, Berdun, J, Usall, J, Ochoa, S, Corripio, I, Jääskeläinen, E. Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study. Jmir Human Factors. 2025; 12DOI:10.2196/67659. PMID:40372941. IF:(Q/D).

Lhoëst, MTL, Martínez, A, Garcia, E, Dandurand, J, Polishchuk, A, Benitez-Amaro, A, Cenarro, A, Civeira, F, Bernabé, A, Vilades, D, Escolà-Gil, JC, Samouillan, V, Llorente-Cortes, V. ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients. JOURNAL OF LIPID RESEARCH. 2025; 66(1)DOI:10.1016/j.jlr.2024.100703. PMID:39557294. IF:4.100(Q2/4D).

Bartrés-Faz, D, Demnitz-King, H, Cabello-Toscano, M, Vaqué-Alcázar, L, Saunders, R, Touron, E, Cattaneo, G, Gonneaud, J, Klimecki, O, Bargalló, N, Sánchez-Solana, J, Tormos, JM, Chételat, G, Pascual-Leone, A, Marchant, NL, Andre, C, Bachelet, R, Lugo, SB, Chocat, A, Collette, F, Coll-Padros, N, Dautricourt, S, de la Sayette, V, Delarue, M, Devouge, EF, Frison, E, Goldet, K, Jessen, F, Krolak-Salmon, P, Kuhn, E, Landeau, B, Lefranc, V, Lutz, A, Mezenge, F, Meiberth, D, Michel, L, Molinuevo, JL, Ourry, V, Poisnel, G, Quillard, A, Rauchs, G, Salmon, E, Schild, AK, Schimmer, C, Smagghe, D, Smith, R, Schlosser, M, Vuilleumier, P, Wallet, C, Walker, Z, Whitfield, T, Wirth, M. Psychological profiles associated with mental, cognitive and brain health in middle-aged and older adults. Nature Mental Health. 2025; 3(1)DOI:10.1038/s44220-024-00361-8. PMID:. IF:(Q/D).

Jerele, C, Tzortzakakis, A, Nemy, M, Rennie, A, Arranz, J, Montal, V, Bejanin, A, Aarsland, D, Westman, E, Fortea, J, Lleó, A, Alcolea, D, Kramberger, MG, Ferreira, D. Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum. Brain Communications. 2025; 7(3)DOI:10.1093/braincomms/fcaf173. PMID:40391186. IF:(Q/D).

Heredia-Lidón, A, García-Mascarell, C, Echeverry-Quiceno, LM, Hostalet, N, Herrera-Escartín, D, González, A, Pomarol-Clotet, E, Fortea, J, Fatjó-Vilas, M, Martínez-Abadías, N, Sevillano, X. A Critical Comparison Between Template-Based and Architecture-Reused Deep Learning Methods for Generic 3D Landmarking of Anatomical Structures. Shape In Medical Imaging, Shapemi 2024. 2025; 15275DOI:10.1007/978-3-031-75291-9_8. PMID:. IF:(Q/D).

Zhu, NL, Altuna, M, Arranz, J, Rodriguez-Baz, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Carrera-Vega, M, Romero, S, Fortea, J, Lleo, A, Giménez, S, Alcolea, D. Sleep-related changes in astrocytic biomarkers are modulated by APOE e4 genotype in cognitively unimpaired adults. Brain Communications. 2025; 7(6)DOI:10.1093/braincomms/fcaf437. PMID:41268178. IF:(Q/D).